Holen Sie sich die Stockscreener-App
1.75
2.94%
0.05
Handel nachbörslich:
1.71
-0.04
-2.29%
Schlusskurs vom Vortag:
$1.70
Offen:
$1.7
24-Stunden-Volumen:
309.99K
Relative Volume:
0.72
Marktkapitalisierung:
$240.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-4.7297
EPS:
-0.37
Netto-Cashflow:
$-42.28M
1W Leistung:
+2.94%
1M Leistung:
-9.33%
6M Leistung:
+2.94%
1J Leistung:
-5.91%
1-Tages-Spanne:
$1.68
$1.795
1-Wochen-Bereich:
$1.58
$1.83
52-Wochen-Spanne:
$0.765
$2.34
Compass Therapeutics Inc Stock (CMPX) Company Profile
Firmenname
Compass Therapeutics Inc
Sektor
Branche
Telefon
617-500-8099
Adresse
80 GUEST STREET, BOSTON
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-31 | Eingeleitet | Jefferies | Buy |
| 2023-01-27 | Eingeleitet | Stifel | Buy |
| 2022-05-23 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-03-15 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-01-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Raymond James | Outperform |
| 2021-12-20 | Eingeleitet | SVB Leerink | Outperform |
| 2021-12-15 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten
Treatment Resistant Depression Pipeline Therapeutics, - openPR
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Compass delays anticipated psilocybin readout, cuts staff - Yahoo Finance
Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024 - MD Magazine
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat
Treatment Resistant Depression Clinical Trials 2024: FDA - openPR
Cholangiocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail
Can you now get a good deal on Compass Therapeutics Inc’s shares? - US Post News
Financial Snapshot: Analyzing Compass Therapeutics Inc (CMPX)’s Key Ratio Metrics - The Dwinnex
CMPX’s 2023 Market Dance: Up 26.92% – Time to Invest? - The InvestChronicle
Renaissance Technologies LLC Decreases Position in Imperial Petroleum Inc. (NASDAQ:IMPP) - Defense World
JetBlue Airways (NASDAQ:JBLU) Raised to “Sell” at StockNews.com - Defense World
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR
Silicon Laboratories Inc. (NASDAQ:SLAB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - ForexTV.com
Compass Therapeutics Announces Upcoming Poster Presentation - GlobeNewswire
Compass Therapeutics Inc (CMPX)’s stock price range in the last year - US Post News
American Century Companies Inc. Cuts Stake in Compass Minerals International, Inc. (NYSE:CMP) - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat
Rhumbline Advisers Takes Position in LINKBANCORP, Inc. (NASDAQ:LNKB) - Defense World
Rhumbline Advisers Trims Holdings in Pembina Pipeline Co. (NYSE:PBA) - Defense World
Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World
NSK (OTCMKTS:NPSKY) Stock Price Passes Above 50-Day Moving Average of $10.02 - Defense World
PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World
Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World
Gencor Industries, Inc. (NASDAQ:GENC) Shares Acquired by Renaissance Technologies LLC - Defense World
First Trust Cloud Computing ETF (NASDAQ:SKYY) Sets New 52-Week High at $103.17 - Defense World
Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR
Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News
Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle
TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail
Compass Diversified (NYSE:CODI) Insider Acquires $109,350.00 in Stock - Defense World
Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Oppenheimer Asset Management Inc. Invests $195,000 in Compass Minerals International, Inc. (NYSE:CMP) - Defense World
Invesco Plc (IVZ-N) QuotePress Release - The Globe and Mail
Compass, Inc. (NYSE:COMP) Short Interest Down 6.0% in August - Defense World
Excalibur (Cayman) Ltd Svf Sells 7,500,000 Shares of Compass, Inc. (NYSE:COMP) Stock - Defense World
A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News
Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) - MSN
Head-To-Head Analysis: Galera Therapeutics (NASDAQ:GRTX) & Galectin Therapeutics (NASDAQ:GALT) - Defense World
Ladenburg raises Compass Therapeutics shares to Buy rating with no target change - Investing.com Canada
Compass Therapeutics (NASDAQ:CMPX) Lifted to Buy at LADENBURG THALM/SH SH - MarketBeat
Executive team - Compass Pathways
National Bank of Canada FI Boosts Position in VICI Properties Inc. (NYSE:VICI) - Defense World
Upward Trajectory: Compass Therapeutics Inc (CMPX) Posts a Slidee, Closing at 1.49 - The Dwinnex
Enphase Energy, Inc. (NASDAQ:ENPH) Shares Sold by Panagora Asset Management Inc. - Defense World
Panagora Asset Management Inc. Invests $323,000 in Ring Energy, Inc. (NYSEAMERICAN:REI) - Defense World
Fox Co. (NASDAQ:FOXA) Shares Sold by Panagora Asset Management Inc. - Defense World
Genworth Financial, Inc. (NYSE:GNW) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Tobam Has $3.27 Million Position in Meta Platforms, Inc. (NASDAQ:META) - Defense World
Panagora Asset Management Inc. Lowers Stake in Quad/Graphics, Inc. (NYSE:QUAD) - Defense World
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):